
International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: unknown, P. 125064 - 125064
Published: Dec. 1, 2024
Language: Английский
International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: unknown, P. 125064 - 125064
Published: Dec. 1, 2024
Language: Английский
Brain Behavior and Immunity, Journal Year: 2024, Volume and Issue: 123, P. 903 - 913
Published: Nov. 1, 2024
Language: Английский
Citations
0International Journal of Nanomedicine, Journal Year: 2024, Volume and Issue: Volume 19, P. 12957 - 12973
Published: Dec. 1, 2024
As a type of transdermal drug delivery system (TDDS), Microneedles (MNs) have garnered significant attention from researchers due to their ability penetrate the stratum corneum (SC) skin, enhance permeability and bioavailability, avoid first-pass metabolism, cause minimal damage skin. This makes them particularly suitable for localized delivery. Dissolvable microneedles (DMNs) can encapsulate sensitive particles, provide high drug-loading capacity, possess biodegradability biocompatibility, attracting extensive research interest. Chitosan (CS) has been selected as matrix manufacturing DMNs its excellent properties, including not eliciting an immune response in vivo having active functional groups such hydroxyl amino that allow modifications impart appropriate mechanical strength functionality specific applications. paper provides comprehensive review status various chitosan-based (CSMNs), explores mechanisms dissolution vivo, discusses applications promoting wound healing, delivering macromolecular drugs, vaccine delivery, anti-tumor therapies.
Language: Английский
Citations
0International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: unknown, P. 125064 - 125064
Published: Dec. 1, 2024
Language: Английский
Citations
0